Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Noriko Yoshida

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
BMJ Open|July 28, 2021
Study protocol for a multicentre, open-label, single-arm phase I/II trial to evaluate the safety and efficacy of ripasudil 0.4% eye drops for retinopathy of prematurityMitsuru Arima, Hirosuke Inoue, Shintaro Nakao, et al.
PNAS Nexus|May 9, 2022
Circulating inflammatory monocytes oppose microglia and contribute to cone cell death in retinitis pigmentosaJun Funatsu, Yusuke Murakami, Shotaro Shimokawa, et al.
Malaria Journal|June 24, 2020
Plasmodium vivax liver stage assay platforms using Indian clinical isolatesPradeep A Subramani, Neha Vartak-Sharma, Seetha Sreekumar, et al.
Plos One|July 2, 2026
Protocol for the SACLA trial: Efficacy and safety of subretinal monteplase for submacular hemorrhage in a phase II single-arm multicenter decentralized clinical trialNoriko Yoshida, Yuko Kobayakawa, Kouta Funakoshi, et al.
Japanese Journal of Ophthalmology|July 26, 2024
Safety and efficacy of ripasudil eye drops in preterm infants with retinopathy of prematurity: phase 1/2, open label, single-arm trialMitsuru Arima, Hirosuke Inoue, Akiko Misumi, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
BMJ Open|July 28, 2021
Study protocol for a multicentre, open-label, single-arm phase I/II trial to evaluate the safety and efficacy of ripasudil 0.4% eye drops for retinopathy of prematurityMitsuru Arima, Hirosuke Inoue, Shintaro Nakao, et al.
PNAS Nexus|May 9, 2022
Circulating inflammatory monocytes oppose microglia and contribute to cone cell death in retinitis pigmentosaJun Funatsu, Yusuke Murakami, Shotaro Shimokawa, et al.
Malaria Journal|June 24, 2020
Plasmodium vivax liver stage assay platforms using Indian clinical isolatesPradeep A Subramani, Neha Vartak-Sharma, Seetha Sreekumar, et al.
Plos One|July 2, 2026
Protocol for the SACLA trial: Efficacy and safety of subretinal monteplase for submacular hemorrhage in a phase II single-arm multicenter decentralized clinical trialNoriko Yoshida, Yuko Kobayakawa, Kouta Funakoshi, et al.
Japanese Journal of Ophthalmology|July 26, 2024
Safety and efficacy of ripasudil eye drops in preterm infants with retinopathy of prematurity: phase 1/2, open label, single-arm trialMitsuru Arima, Hirosuke Inoue, Akiko Misumi, et al.
Pageof 7